NYXH (Nyxoah) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 27, 2026)


NYXH Nyxoah SA NYXH
65 GF Score
Price $1.67
GF Value $27.44
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Nyxoah Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Nyxoah's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

NYXH vs ISRG, BDX, MDLN: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Instruments & Supplies subindustry, Nyxoah's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nyxoah Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nyxoah's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Nyxoah's Margin of Safety % (DCF Earnings Based) falls into.


NYXH
65GF Score
Nyxoah SA NYXH
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nyxoah (NYXH) Overvalued in 2026?

Based on GuruFocus' analysis, Nyxoah stock appears to be undervalued. The current stock price of $1.67 is trading 93.9% below its estimated GF Value™ of $27.44. GuruFocus considers Nyxoah to be Possible Value Trap.

Key valuation signals for NYXH:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $27.44 vs. price of $1.67 (93.9% below fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the NYXH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nyxoah Business Description

Other Exchanges 5YI:GermanyNYXH:Belgium
Address Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
65GF Score

Get the complete analysis for NYXH

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.67
Price
$27.44
GF Value